Francesco De Rubertis

age:

54 years

appointments:

17 active

10 prior

primary industry:

Scientific research and development

about Francesco

Since 2019, Mr De Rubertis has been a director of 27 companies, the current directorship have a combined turnover of approximately £18.9m.

Combined Valuation

£539.1m

Combined Turnover

£18.9m

active directorships over time

company
turnover
valuation
start
end
status
role
centessa pharmaceuticals plc£5.4m£408.2mNov 2020-OpenDirector
centessa pharmaceuticals (uk) limited-£87.7mDec 2020-OpenDirector
z factor limited-£9.4mOct 2020-OpenDirector
levicept ltd£9.3m£5.7mNov 2020-OpenDirector
imhotex limited£208.4k£5.1mFeb 2020-OpenDirector
kaerus bioscience limited£178.5k£4.1mJun 2021-OpenDirector
perfect balance bio limited£375.1k£2.4mOct 2020-OpenDirector
ottimo pharma limited£383.4k£1.9mNov 2020-OpenDirector
ultrahuman one limited£347.1k£585.4kNov 2020-OpenDirector
ultrahuman thirteen limited£346.8k£584.8kNov 2020-OpenDirector
ultrahuman twelve limited£344.3k£580.7kNov 2020-OpenDirector
ultrahuman nine limited£343.1k£578.6kNov 2020-OpenDirector
ultrahuman ten limited£343k£578.5kNov 2020-OpenDirector
ultrahuman seven limited£307.4k£457.2kNov 2020-OpenDirector
pandeia therapeutics limited£144.1k£168.4kSep 2019-OpenDirector
bplete limited-£2Nov 2023-OpenDirector